Arisa Akashi Sin
Lawyers

Filters
Thimble Point Acquisition $276 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
23andMe $3.5 billion merger with Virgin Group’s VG Acquisition
We are advising a SPAC on its merger with 23andMe
Precigen $129 million common stock offering
We advised the underwriters in connection with the SEC-registered equity offering
Hamilton Lane Alliance Holdings I $270 million IPO
We advised the underwriters on the SPAC IPO and NYSE listing
LendingTree $872 million secondary offering
Davis Polk advised LendingTree, Inc. in connection with the $872 million secondary offering of 2,955,984 shares of its common stock by Ventures Holdco II, LLC, which is a wholly owned…
VG Acquisition $480 million IPO
Davis Polk advised VG Acquisition Corp. on its $480 million initial public offering of 48,000,000 units. Each unit had an initial offering price of $10 and consists of one Class A ordinary…
Gilead Sciences $7.25 billion senior notes offering
Davis Polk advised Gilead Sciences, Inc. in connection with an SEC-registered offering of $7.25 billion aggregate principal amount of senior notes, consisting of (i) $500 million aggregate…
Broadstone Acquisition $300 million IPO
Davis Polk advised the underwriter in connection with the initial public offering of 30,000,000 units of Broadstone Acquisition Corp., for aggregate proceeds of $300 million. Each unit…
Prime Impact Acquisition I $300 million IPO
Davis Polk advised the underwriters in connection with the initial public offering of 30,000,000 units of Prime Impact Acquisition I, for aggregate proceeds of $300 million. Each unit…
Constellation Pharmaceuticals $192.5 million stock offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $192.5 million offering of common stock of Constellation…